Literature DB >> 3549959

Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.

P J Barr, H L Gibson, V Enea, D E Arnot, M R Hollingdale, V Nussenzweig.   

Abstract

DNA coding for 234 amino acids of the circumsporozoite (CS) protein of Plasmodium vivax was incorporated into yeast expression vectors. The DNA encoded all the repeat domain and codons for a highly conserved sequence, KLKQP, found in CS proteins from all malaria parasites. Yeast cells transformed with these autonomously replicating plasmids expressed, upon induction, high levels of the CS polypeptide. The malaria antigen was purified in good yields from yeast extracts and was injected into mice using alum as adjuvant. The antibodies recognized the authentic CS protein, and at high dilutions, they inhibited the invasion of hepatocytes by sporozoites in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549959      PMCID: PMC2188575          DOI: 10.1084/jem.165.4.1160

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  The circumsporozoite gene of the Plasmodium cynomolgi complex.

Authors:  M R Galinski; D E Arnot; A H Cochrane; J W Barnwell; R S Nussenzweig; V Enea
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

2.  Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies.

Authors:  M R Hollingdale; E H Nardin; S Tharavanij; A L Schwartz; R S Nussenzweig
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

3.  Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.

Authors:  P Valenzuela; A Medina; W J Rutter; G Ammerer; B D Hall
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

4.  Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

Authors:  D F Clyde
Journal:  Am J Trop Med Hyg       Date:  1975-05       Impact factor: 2.345

5.  Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae.

Authors:  A J Brake; J P Merryweather; D G Coit; U A Heberlein; F R Masiarz; G T Mullenbach; M S Urdea; P Valenzuela; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA.

Authors:  E M Scolnick; A A McLean; D J West; W J McAleer; W J Miller; E B Buynak
Journal:  JAMA       Date:  1984-06-01       Impact factor: 56.272

7.  Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein.

Authors:  G N Godson; J Ellis; P Svec; D H Schlesinger; V Nussenzweig
Journal:  Nature       Date:  1983 Sep 1-7       Impact factor: 49.962

8.  Structure of the plasmodium knowlesi gene coding for the circumsporozoite protein.

Authors:  L S Ozaki; P Svec; R S Nussenzweig; V Nussenzweig; G N Godson
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

9.  Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

Authors:  J B Dame; J L Williams; T F McCutchan; J L Weber; R A Wirtz; W T Hockmeyer; W L Maloy; J D Haynes; I Schneider; D Roberts
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

10.  Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.

Authors:  E H Nardin; V Nussenzweig; R S Nussenzweig; W E Collins; K T Harinasuta; P Tapchaisri; Y Chomcharn
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  16 in total

1.  Identification of a T-cell epitope on the circumsporozoite protein of Plasmodium vivax.

Authors:  F W George; J L Law; K A Rich; W J Martin
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 2.  Malaria vaccine.

Authors:  U Certa
Journal:  Experientia       Date:  1991-02-15

3.  Does biased gene conversion influence polymorphism in the circumsporozoite protein-encoding gene of Plasmodium vivax?

Authors:  D E Arnot; J W Barnwell; M J Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.

Authors:  Anjali Yadava; Jetsumon Sattabongkot; Michael A Washington; Lisa A Ware; Victoria Majam; Hong Zheng; Sanjai Kumar; Christian F Ockenhouse
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

6.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

7.  Antibody response of humans to the circumsporozoite protein of Plasmodium vivax.

Authors:  E D Franke; C M Lucas; E San Roman
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Quantitative evaluation of the chicken lysozyme epitope in the HyHEL-10 Fab complex: free energies and kinetics.

Authors:  A Rajpal; M G Taylor; J F Kirsch
Journal:  Protein Sci       Date:  1998-09       Impact factor: 6.725

9.  Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax.

Authors:  Y Zevering; C Khamboonruang; K Rungruengthanakit; L Tungviboonchai; J Ruengpipattanapan; I Bathurst; P Barr; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.